Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Menopause causes significant changes in the vaginal introitus, but less so in the labia majora, which may lead to symptoms of vaginal atrophy.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Adrenal tumors can cause hair loss and high testosterone in women.

Some types of hair loss can be reversed, others are permanent, and treatments vary by type.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Spironolactone is effective for treating female hair loss, with new treatments like clascoterone showing promise.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

A young man was diagnosed with a rare hair loss condition usually seen in older women.

The combination of oral finasteride and dutasteride with topical minoxidil effectively promotes new hair growth in most people, with minimal side effects.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Hepatitis C treatment may cause frontal fibrosing alopecia.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Diffuse lichen planopilaris greatly reduces quality of life.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Use a combination of oral dutasteride, topical treatments, and hydroxychloroquine to manage frontal fibrosing alopecia.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

PRP treatments have shown mixed results for healing, and future research should focus on how PRP is used and which type is used.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Hair transplanting is a useful, often overlooked treatment for female pattern hair loss.

Understanding hair follicle structure is key for treating hair disorders and could help develop new treatments.

Some women with common hair loss may develop permanent hair loss.